纳米标准与检测重点实验室第338期学术报告

报告题目：Photonic Biosensing Devices for Medical Diagnostics

报告人：Prof Ali Yetisen

时  间：2025年7月17日（星期四）上午10:00

地  点：新楼第六会议室

主持人：孙佳姝 研究员

报告内容：

Real-time biochemical sensing technologies based on colorimetric, fluorescent, and photonic crystal platforms are enabling a paradigm shift in clinical diagnostics and point-of-care healthcare. In this seminar, Yetisen will present recent advances in the engineering of photonic biosensors that enable quantitative detection of clinically relevant biomarkers across wearable, implantable, and in vitro diagnostic systems. These technologies offer high sensitivity, multiplexing capabilities, and compatibility with smartphone-based spectrophotometric readouts for low -cost and scalable deployment. Pilot clinical studies will be discussed to demonstrate translational potential in metabolic, inflammatory, and neurological monitoring. The presentation will also address pathways to commercialization, including regulatory considerations and the development of startup companies aimed at delivering personalized and proactive medical diagnostics.

报告人简介：

Dr. Yetisen is an Associate Professor in the Department of Chemical Engineering at Imperial College London. He holds a Ph.D. in Chemical Engineering (Biotechnology) from the University of Cambridge. He has worked as a Tosteson Fellow at Harvard University and Massachusetts General Hospital. Dr. Yetisen has received numerous international awards, including the IChemE Nicklin Medal, the Birmingham Fellowship, and the Alexander von Humboldt Fellowship. He is a Fellow of the Royal Society of Chemistry and the Institute of Physics. Additionally, he serves as an Associate Editor for the journals Sensors & Diagnostics (Royal Society of Chemistry) and Aggregate (Wiley).